NO930820L - Patogen-spesifikk ctl terapi - Google Patents

Patogen-spesifikk ctl terapi

Info

Publication number
NO930820L
NO930820L NO93930820A NO930820A NO930820L NO 930820 L NO930820 L NO 930820L NO 93930820 A NO93930820 A NO 93930820A NO 930820 A NO930820 A NO 930820A NO 930820 L NO930820 L NO 930820L
Authority
NO
Norway
Prior art keywords
pathogen
specific ctl
ctl therapy
patient
intracellular pathogen
Prior art date
Application number
NO93930820A
Other languages
English (en)
Other versions
NO930820D0 (no
Inventor
Judy Lieberman
Malcolm Gefter
Original Assignee
Immulogic Pharma Corp
New England Medical Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1991/006441 external-priority patent/WO1992004462A1/en
Application filed by Immulogic Pharma Corp, New England Medical Center Inc filed Critical Immulogic Pharma Corp
Publication of NO930820L publication Critical patent/NO930820L/no
Publication of NO930820D0 publication Critical patent/NO930820D0/no

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Fremgangsmåte beskrives for behandling av en pasient infisert med en intracellulær patogen, hvilket omfatter til- førsel til pasienten av en intracellulær patogen-spesifikk, cytotoksisk T lymfocyt-stimulerend-2 antigen, eller et preparat av pasientens lymfocyter anriket for intracellulære patogen- spesif ikke cytotoksiske T lymofocyter.
NO930820A 1990-09-06 1993-03-05 Patogen-spesifikk ctl terapi NO930820D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57882890A 1990-09-06 1990-09-06
PCT/US1991/006441 WO1992004462A1 (en) 1990-09-06 1991-09-06 Pathogen-specific ctl therapy

Publications (2)

Publication Number Publication Date
NO930820L true NO930820L (no) 1993-03-05
NO930820D0 NO930820D0 (no) 1993-03-05

Family

ID=26783372

Family Applications (1)

Application Number Title Priority Date Filing Date
NO930820A NO930820D0 (no) 1990-09-06 1993-03-05 Patogen-spesifikk ctl terapi

Country Status (1)

Country Link
NO (1) NO930820D0 (no)

Also Published As

Publication number Publication date
NO930820D0 (no) 1993-03-05

Similar Documents

Publication Publication Date Title
DE69129800D1 (de) Behandlung von menschlichen retrovirus-infektionen mit 2',3'-dideoxyinosin
PL309002A1 (en) Therapeutic application of chimeric and radiotracer labelled antibodies, directed against the differentation antigen limited to human lymphocytes b, for treating lymphoma from lymphocytes b
DK1005870T3 (da) Terapeutisk anvendelse af kimæriske antistoffer mod humant B-lymfocytdifferentieringsantigen til behandling af B-cellelymfom
AU4951196A (en) Vaccines for plague
DE69127470T2 (de) Verstärkung der unterdrückungsregulation von autoimmunkrankheiten durch orale oder enterale verabreichung von autoantigenen
FI19991893A (fi) Säädellysti budesonidia vapauttava oraalisesti annettava koostumus ja budesonidin käyttö
ATE119766T1 (de) Zubereitung für den magen.
EP1298203A3 (en) Diagnosis and treatment of autoimmune diseases
CA2098021A1 (en) Composition Used as a Therapeutic Agent Against Chronic Viral Hepatic Diseases
NO922936D0 (no) Fremstilling av fettsyremedikamenter
ATE193442T1 (de) 3,4-diarylchromane zur behandlung von dermatitis
GR1000419B (el) Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου.
SE8204873D0 (sv) Farmaceutiska preparat, innefattande humant insulin och human c-peptid
DE3478749D1 (en) Covalently bound heparin - antithrombin-iii complex, method for its preparation and its use for treating thromboembolism
NO930820L (no) Patogen-spesifikk ctl terapi
ATE58478T1 (de) Zubereitungen und verfahren zum schutz von tlymphozyten gegen das krankheitsagens von lymphadenopathie und vom erworbenen immundepressionsyndrom.
ATE157543T1 (de) Pharmazeutische zusammensetzung
ATE111485T1 (de) Peptidbehandlung von hartnäckigen infektionskrankheiten.
SE8204872D0 (sv) Farmaceutiska preparat, innefattande humant insulin, human c-peptid och humant proinsulin
AU8501191A (en) Cross-reactive influenza a immunization
Mikhailov et al. The influence of gamma irradiation on hepatitis B virus components and delta antigen.
SU1797350A1 (ru) Способ обнаружения вируса иммунодефицита человека
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов
SE8104690L (sv) Vaccin mot kikhosta
Zourbas et al. Immunization of dental surgeons against hepatitis B virus infection.